Confidant
- 02 Mar 2007 10:50
Not professing skills in this area but attracted to company by its client list
Pfizer, Johnson&Johnson, Roche and Novartis all clients to name but a few
Company effectively reproduces human response to possible drugs, creams etc . Effectively builds a"virtual patient". Others do this but not sure they have the client list
Seems to get repeat business plus looks to be on c2x - 2.5x sales year just ended. IMHO too low for such a stock. Recent news in Feb all good and suggests on certain ventures they get some interest in new compunds developed
Listed above this price -- 85p --- this time last year. Results should be in next few weeks. Any thoughts?
Confidant
- 02 Mar 2007 15:14
- 8 of 19
It looks like they should be making money this year I would agree -- I have no idea how much at mo
Yes have other deferred income but maybe the 1H was a bit exceptional on how it was pulled through -- comapnay mentioned it and I'm trying to look on the downside. Happy to see some clarification at results but expect substantially lower normalised rev in 2H with no profit this year. But I am guessing using $10m as "exceptional" 1H revenue to guide me
goldfinger
- 02 Mar 2007 23:01
- 9 of 19
Still interested
Confidant
- 05 Mar 2007 15:33
- 11 of 19
What's that Soul --- the wife is holding the purse strings ???? ;-)
hewittalan6
- 05 Mar 2007 18:11
- 13 of 19
Clearence from a compliance department??
You'll get an audience with the pope quicker than that.
Confidant
- 12 Mar 2007 08:45
- 15 of 19
Sales warnings ---- profit warning
Apologies for starting thread -- effectively a whipping boy for the major pharmas
Price taker not maker
Apologies again
hewittalan6
- 12 Mar 2007 09:27
- 18 of 19
Don't beat yourself up over it!!!
You started the thread with integrity.
That is the important point. It is those that start them without integrity that should apologise.
Just glad I never got in, though I was watching it!! ;-)
Alan
Confidant
- 12 Mar 2007 11:55
- 19 of 19
thx for the comments. Will stay away from this now, as can't see good news or a profit for long time given they say an adjustment to business will be needed to cut costs